Indications
Therapeutic Asset Ratings
18,134 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Catequentinib
Refractory Malignant Neoplasm
Nanfang Hospital, Southern Medical University
P3
BB
(65)
Celecoxib
Rectal Carcinoma
Zhejiang University
P3
BB
(65)
Cetirizine
Breast Cancer
Maryam Lustberg
P3
BB
(65)
Copanlisib
Non-Hodgkin Lymphoma
OHSU Knight Cancer Institute
P3
BB
(65)
Crizotinib
Hepatocellular Carcinoma
Ariad Pharmaceuticals
P3
BB
(65)
Cyclophosphamide
Breast Carcinoma In Situ
Roswell Park Cancer Institute
P3
BB
(65)
Cyclophosphamide
Cervical Cancer
Merck Sharp & Dohme LLC
P3
BB
(65)
Cyclophosphamide
Esophageal Cancer
Sutro Biopharma, Inc.
P3
BB
(65)
Cyclophosphamide
Hormone Receptor-Positive Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(65)
Cyclophosphamide
Metastatic Prostate Carcinoma
Beijing Biotech
P3
BB
(65)
Cyclophosphamide
Non-Cutaneous Melanoma
H. Lee Moffitt Cancer Center and Research Institute
P3
BB
(65)
Cyclophosphamide
Prostate Cancer
Icahn School of Medicine at Mount Sinai
P3
BB
(65)
Dapagliflozin
Heart Failure
University Medical Centre Ljubljana
P3
BB
(65)
Darolutamide
Prostate Adenocarcinoma
Region Stockholm
P3
BB
(65)
Decitabine
Acute Myeloblastic Leukemia Without Maturation
Roswell Park Cancer Institute
P3
BB
(65)
Desferrioxamine B
Stroke Disorder
The George Institute
P3
BB
(65)
Dfn-11 (Sumatriptan Injection)
Migraine With Aura
University of Aarhus
P3
BB
(65)
Diphenhydramine
Breast Cancer
Beijing Biostar Pharmaceuticals Co., Ltd.
P3
BB
(65)
Docetaxel
Carcinoma Of The Ampulla Of Vater
Minia University
P3
BB
(65)
Docetaxel
Ovarian Brenner Tumor
National Cancer Institute (NCI)
P3
BB
(65)
Docetaxel
Hypogonadism
SWOG Cancer Research Network
P3
BB
(65)
Docetaxel
Endometrial Cancer
Merck Sharp & Dohme LLC
P3
BB
(65)
Docetaxel
Head And Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
P3
BB
(65)
Docetaxel
Ovarian Serous Adenocarcinoma
Genelux Corporation
P3
BB
(65)
Docetaxel
Ovarian Endometrioid Adenocarcinoma
Genelux Corporation
P3
BB
(65)
Showing 3876 to 3900 of 18,134 assets
Previous
Page 156 of 726
Next